rs141859946

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_153717.3(EVC):​c.1369G>A​(p.Glu457Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00264 in 1,614,114 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0019 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0027 ( 8 hom. )

Consequence

EVC
NM_153717.3 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:10

Conservation

PhyloP100: 2.55

Publications

7 publications found
Variant links:
Genes affected
EVC (HGNC:3497): (EvC ciliary complex subunit 1) This gene encodes a protein containing a leucine zipper and a transmembrane domain. This gene has been implicated in both Ellis-van Creveld syndrome (EvC) and Weyers acrodental dysostosis. [provided by RefSeq, Jul 2008]
CRMP1 (HGNC:2365): (collapsin response mediator protein 1) This gene encodes a member of a family of cytosolic phosphoproteins expressed exclusively in the nervous system. The encoded protein is thought to be a part of the semaphorin signal transduction pathway implicated in semaphorin-induced growth cone collapse during neural development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0052634776).
BP6
Variant 4-5753838-G-A is Benign according to our data. Variant chr4-5753838-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 349176.We mark this variant Benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS2
High Homozygotes in GnomAdExome4 at 8 AD,Unknown,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EVCNM_153717.3 linkc.1369G>A p.Glu457Lys missense_variant Exon 10 of 21 ENST00000264956.11 NP_714928.1 P57679

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EVCENST00000264956.11 linkc.1369G>A p.Glu457Lys missense_variant Exon 10 of 21 1 NM_153717.3 ENSP00000264956.6 P57679
EVCENST00000509451.1 linkc.1369G>A p.Glu457Lys missense_variant Exon 10 of 12 1 ENSP00000426774.1 E9PCN4
EVCENST00000514919.1 linkn.432G>A non_coding_transcript_exon_variant Exon 2 of 2 2
CRMP1ENST00000506216.5 linkn.1648-5526C>T intron_variant Intron 12 of 12 5

Frequencies

GnomAD3 genomes
AF:
0.00192
AC:
292
AN:
152176
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000700
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00157
Gnomad ASJ
AF:
0.00806
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00279
Gnomad OTH
AF:
0.00573
GnomAD2 exomes
AF:
0.00208
AC:
522
AN:
251470
AF XY:
0.00214
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.00145
Gnomad ASJ exome
AF:
0.00784
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000785
Gnomad NFE exome
AF:
0.00289
Gnomad OTH exome
AF:
0.00293
GnomAD4 exome
AF:
0.00272
AC:
3970
AN:
1461820
Hom.:
8
Cov.:
35
AF XY:
0.00269
AC XY:
1956
AN XY:
727206
show subpopulations
African (AFR)
AF:
0.000508
AC:
17
AN:
33478
American (AMR)
AF:
0.00148
AC:
66
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00727
AC:
190
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000928
AC:
80
AN:
86250
European-Finnish (FIN)
AF:
0.00103
AC:
55
AN:
53416
Middle Eastern (MID)
AF:
0.0119
AC:
68
AN:
5732
European-Non Finnish (NFE)
AF:
0.00298
AC:
3316
AN:
1111996
Other (OTH)
AF:
0.00295
AC:
178
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
248
496
744
992
1240
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00192
AC:
292
AN:
152294
Hom.:
0
Cov.:
33
AF XY:
0.00183
AC XY:
136
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.000698
AC:
29
AN:
41548
American (AMR)
AF:
0.00157
AC:
24
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00806
AC:
28
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000623
AC:
3
AN:
4818
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10624
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00279
AC:
190
AN:
68032
Other (OTH)
AF:
0.00567
AC:
12
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
14
29
43
58
72
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00273
Hom.:
1
Bravo
AF:
0.00204
TwinsUK
AF:
0.00243
AC:
9
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00395
AC:
34
ExAC
AF:
0.00213
AC:
259
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00273
EpiControl
AF:
0.00308

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:10
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:5
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

EVC: BP4, BS2 -

Mar 25, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome Uncertain:1Benign:1
Jun 01, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ellis-van Creveld syndrome Benign:2
Oct 21, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

not specified Benign:1
Aug 17, 2017
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

EVC-related disorder Benign:1
Jun 13, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
17
DANN
Uncertain
1.0
DEOGEN2
Benign
0.076
T;.
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.35
FATHMM_MKL
Benign
0.022
N
LIST_S2
Uncertain
0.86
D;D
M_CAP
Benign
0.0060
T
MetaRNN
Benign
0.0053
T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.6
L;.
PhyloP100
2.5
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-1.1
N;N
REVEL
Benign
0.040
Sift
Benign
0.71
T;T
Sift4G
Benign
0.43
T;T
Polyphen
0.12
B;.
Vest4
0.23
MVP
0.48
ClinPred
0.017
T
GERP RS
5.0
Varity_R
0.13
gMVP
0.093
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141859946; hg19: chr4-5755565; COSMIC: COSV106090590; API